Kevin Punie
@kevinpunie
Medonc @gzaziekenhuizen @AntwerpOncology 🇹🇩Knight to improve outcome of patients w/ breast cancer 🧬 #TNBC #BCY #HereditaryCancer @myBSMO @EORTC_BCG #ESMOYOC
ID:1076032540383809536
https://coi.asco.org/share/2UF-THR4/Kevin%20Punie 21-12-2018 08:32:04
5,1K Tweets
2,7K Followers
1,3K Following
Read why we believe rapid autopsy programmes = a global effort to advance research on metastatic cancer 🤝. They are associated with many challenges, but offer so many opportunities. Lisa Carey, MD, ScM, FASCO Nature Reviews Cancer OncoAlert
nature.com/articles/s4156…
‼️Apply now for the amazing ESMO - Eur. Oncology Virtual Mentorship Program! ⬇️
We built this to help shape young oncologist careers around the 🌍 and we'll match you up with some of the greatest ⭐ in oncology!
Thank you #EBCC14 🇮🇹
3️⃣ magnificent days of Science and Friendship in a beautiful city
Grateful to @breasteuropean & EORTC and our Amazing ambassadors:
Michail ignatiadis FIORITA POULAKAKI Tanja Spanic Icro Meattini Matteo Lambertini, MD PhD Philippe Aftimos, MD MarleenKokLab IR Ioannis Zerdes Ottavia Amato…
#EBCC14 As the last session is about to close we would love to thank all who participated in EBCC-14. Safe journey home and see you in Barcelona for #EBCC15 OncoAlert EORTC Breast Cancer Group G Curigliano MD PhD Michail ignatiadis FIORITA POULAKAKI IR @eortc
An amazing Day TWO of #EBCC14
Our Thanks to the European Breast Cancer Conference (EBCC-14) EORTC
faculty and Staff here in Milan🇮🇹
✅7⃣.4⃣Million Impressions
✅1⃣,2⃣0⃣0⃣Posts
Warm gratitude to the OncoAlert 🚨ambassadors and our Colleagues worldwide for their support in keeping Colleagues up to…
A FULL ROOM AT #EBCC14
WELCOME TO MILAN🇮🇹
Michail ignatiadis FIORITA POULAKAKI Tanja Spanic Icro Meattini Matteo Lambertini, MD PhD Philippe Aftimos, MD MarleenKokLab IR Ioannis Zerdes Ottavia Amato Elisabetta Bonzano Caroline Drukker EORTC Breast Cancer Group EORTC Quality of Life Group (QLG) @breasteuropean Europa Donna Helena Guedes G Curigliano MD PhD…
Congratulations to Christos Sotiriou on his brilliant research journey, which aims to advance our knowledge of #breastcancer and improve care for our patients Institut Jules Bordet Instituut 👏🏻 #scienceaward #EBCC14 EORTC 🧬🔬
Just Presented at DAY 1 #EBCC14 🇮🇹Milan
by chair Michail ignatiadis 🇧🇪 of Institut Jules Bordet Instituut on CPI's
Based on the pivotal Keynote522 trial, neoadjuvant/adjuvant pembrolizumab + chemotherapy is the standard of care for stage II-III early #TNBC
Following Alexandra/Impassion030, upfront…
Impressive talk by Christos Sotiriou on biology of breast cancer for precision medicine. Genomic profiles of tumors, luminal A becoming luminal B 😊 subtypes of TNBC are 5 or more?
European Breast Cancer Conference (EBCC-14) OncoAlert
Europa Donna
Early morning start of #ebcc14 with our lovely chairs Michail ignatiadis and FIORITA POULAKAKI and local chair G Curigliano MD PhD. Three days of exiting sessions and meetings 💕
OncoAlert European Breast Cancer Conference (EBCC-14)
Europa Donna EuropaDonnaSlovenija
A beautiful morning in Milan & a warm welcome from #EBCC14 chairs‼️
Michail ignatiadis FIORITA POULAKAKI & G Curigliano MD PhD 🇧🇪🇬🇷🇮🇹
Tanja Spanic Icro Meattini Matteo Lambertini, MD PhD
Philippe Aftimos, MD MarleenKokLab IR Ioannis Zerdes Ottavia Amato
Elisabetta Bonzano Caroline Drukker EORTC Breast Cancer Group
EORTC Quality of Life Group (QLG) @breasteuropean…
A warm welcome to #EBCC14 in Milan🇮🇹
STILL TIME TO REGISTER !!
LINK: event.eortc.org/ebcc14/individ…
Here is EORTC Young Investigator Helena Guedes 🇵🇹with a warm invite to attend to the Young Investigator session in Milan🇮🇹
Michail ignatiadis FIORITA POULAKAKI Ottavia Amato Tanja Spanic…
Are you a #YoungOncologist looking for personalised guidance to enhance your #CareerDevelopment ? Apply now for the ESMO Virtual Mentorship Programme to receive 1:1 mentorship to address your unmet career development needs.
📌esmo.org/career-develop…
📄Final Results from Randomized Phase III ASCENT Clinical Trial in Metastatic #TripleNegativeBreastCancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression Sara Tolaney Aditya Bardia, MD
👉pubmed.ncbi.nlm.nih.gov/38422473/
Very grateful to be given the opportunity by #AstraZeneca to talk on the impact of data sharing in oncology in wonderful Sofia, Bulgaria!
Milos Icevic Lazar Popovic Mariya Jeliazova
Just in case you missed it, understanding B-cell immunity role in TNBC is 🔑
Great job by Benedetta Conte, Fara Brasó Maristany, with the enlightening leadership of Aleix Prat #PrecisionOncology 👏🏻 Thanks for involving me and congrats to the whole team 💪🏻
Here our novel findings, out in eBioMedicine – The Lancet Discovery Science 👇🏻